Titan (TITC) Q2 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 2025 earnings summary
16 Nov, 2025Executive summary
H1 2025 sales rose 0.4% year-over-year to €1,329 million, with strong performance in the US, Greece, and Egypt despite adverse weather and FX headwinds.
EBITDA increased 2% year-over-year to €287 million, with margin resilience from cost controls and operational efficiencies.
Net profit after tax was €68.4 million, impacted by a €51.9 million one-off loss from the Adocim (Turkey) sale and higher minority interests.
Robust liquidity with net debt at €137 million and leverage at 0.2x EBITDA, supported by IPO proceeds and divestments.
Strategic investments advanced in digitalization, sustainability, and new technologies, including AI rollout and low-carbon initiatives.
Financial highlights
H1 2025 sales: €1,328.6 million (+0.4% YoY); EBITDA: €286.9 million (+2.0% YoY); Net profit: €68.4 million (-54% YoY, adjusted: €120.3 million, -19%).
Q2 2025 sales: €690.2 million (-1.3% YoY); EBITDA: €164.3 million (-4.2% YoY); Net profit: €24.7 million (-74.4% YoY, adjusted: €76.6 million, -20%).
Operating free cash flow at €102 million in H1 2025; net debt decreased by €485 million to €137 million.
Earnings per share (basic) for H1 2025: €0.92 (-54% YoY); adjusted EPS: €1.6 (-19% YoY).
12-month rolling EBITDA more than doubled since 2022, reaching €585.7 million with a 22.1% margin.
Outlook and guidance
Maintains cautiously optimistic outlook for the remainder of 2025, expecting sales growth and EBITDA margin expansion from solid volumes, firm pricing, and efficiency gains.
US market supported by infrastructure and commercial demand, with residential expected to stabilize in 2026.
Greece and Southeast Europe to benefit from infrastructure projects and EU fund absorption, though risks from political instability and fund delays remain.
Egypt expected to deliver improved performance, leveraging export growth, reforms, and public-private partnerships.
Full-year CapEx expected between €250–300 million.
Latest events from Titan
- Record sales and EBITDA in 2025 support a positive outlook and continued margin expansion.TITC
Q4 202519 Mar 2026 - Sales, EBITDA, and net profit surged in H1 2024, with net debt at a record low.TITC
Q2 20242 Feb 2026 - Sales, EBITDA, and net profit rose strongly, with US IPO and green initiatives advancing.TITC
Q3 202416 Jan 2026 - Record sales, profit, and margin growth, with strong outlook and CapEx set to surpass €300m.TITC
Q4 20243 Dec 2025 - EBITDA up 11.7%, net debt halved post-IPO, and outlook remains positive for 2025.TITC
Q1 202520 Nov 2025 - Ambitious 2029 plan targets €4bn sales, €1bn EBITDA, and €500m shareholder returns.TITC
CMD 202520 Nov 2025 - Record EBITDA, sales growth, and reduced net debt with a positive outlook for 2025–2026.TITC
Q3 202513 Nov 2025